Cheryl Eubank

Cheryl Eubank is a global commercial leader with over 15 years of pharmaceutical sales and marketing experience, specializing in pre-launch, launch, and life cycle management across various therapeutic areas. They held academic positions at the University of Leeds before progressing to roles at Shire AG and Shire GmBH, where they led international marketing initiatives in neuroscience and rare diseases. Most recently, Cheryl is the Global Commercial Execution Lead for CV, Bone & Inflammation at Amgen, having previously served as the Europe Commercial Lead in Inflammation. Their expertise includes brand strategy development, project and P&L management, and effective cross-functional team leadership.